New Study Findings from Medical University of Vienna Illuminate Research in Liver Cancer (Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma)

Source :: Immunotherapy Weekly. September 27, 2023, 2403
Publication Year :: 2023
Abstract: 2023 SEP 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New study results on liver cancer have been published. According to news reporting from Vienna, [...]

Subjects :: Oncology, Experimental -- Reports
Tyrosine -- Research -- Reports
Antineoplastic agents -- Research
Phenols -- Reports -- Research
Immunotherapy -- Reports -- Research
Carcinoma -- Care and treatment -- Research
Liver cancer -- Care and treatment -- Research
Cancer -- Care and treatment -- Research
Antimitotic agents -- Research
Health

Tools